You are using an outdated browser. Please
upgrade your browser to improve your experience.
The myHizentra™ App has been developed by CSL Behring (Australia) Pty Ltd
MyHizentra™ Patient App
by CSL Behring LLC
What is it about?
The myHizentra™ App has been developed by CSL Behring (Australia) Pty Ltd. ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia.
App Screenshots
App Store Description
The myHizentra™ App has been developed by CSL Behring (Australia) Pty Ltd. ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia.
This app is designed to be used only by Australian patients prescribed HIZENTRA®. An activation code is therefore required to access the app. Australian patients can contact their nurse or doctor to request an activation code.
The app includes information about HIZENTRA and a patient diary to record HIZENTRA infusions. In the diary, patients can also track their symptoms and both the symptoms and infusion history can be exported to send to a patients nurse or doctor.
The app also includes an infusion reminder service and barcode scanner functionality so patient can easily record and manage their HIZENTRA stock in the home.
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
